Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Clinical trial NCT01521897 · COMPLETED

Trial details

NCT number: NCT01521897
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Pneumococcal Vaccine Streptococcus Pneumoniae

Start date: 2010-09-01
Primary completion: 2013-01-01
Enrollment: 1143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.